Your browser doesn't support javascript.
loading
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt, Marlies; Demeyer, Sofie; Broux, Michaël; De Bie, Jolien; Bornschein, Simon; Mentens, Nicole; Vandepoel, Roel; Geerdens, Ellen; Radaelli, Enrico; Bornhauser, Beat C; Kulozik, Andreas E; Meijerink, Jules P; Bourquin, Jean-Pierre; de Bock, Charles E; Cools, Jan.
Afiliação
  • Vanden Bempt M; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Demeyer S; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Broux M; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • De Bie J; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Bornschein S; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Mentens N; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Vandepoel R; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Geerdens E; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Radaelli E; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium.
  • Bornhauser BC; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Kulozik AE; Department of Pediatric Hematology and Oncology, Heidelberg University Children's Hospital, Heidelberg, Germany; Hopp Children's Cancer Center at the NCT Heidelberg, Heidelberg, Germany.
  • Meijerink JP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Bourquin JP; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • de Bock CE; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium. Electronic address: charles.debock@kuleuven.vib.be.
  • Cools J; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium. Electronic address: jan.cools@kuleuven.vib.be.
Cancer Cell ; 34(2): 271-285.e7, 2018 08 13.
Article em En | MEDLINE | ID: mdl-30107177

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-abl / Proteínas Proto-Oncogênicas / Elementos Facilitadores Genéticos / Proteínas de Homeodomínio / Complexo de Proteínas Formadoras de Poros Nucleares / Fator de Transcrição STAT5 / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Cell Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-abl / Proteínas Proto-Oncogênicas / Elementos Facilitadores Genéticos / Proteínas de Homeodomínio / Complexo de Proteínas Formadoras de Poros Nucleares / Fator de Transcrição STAT5 / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Cell Ano de publicação: 2018 Tipo de documento: Article